The story describes the design of the two similar studies of male circumcision and reduced HIV in African men who engage in heterosexual intercourse. The story provides both absolute and relative data; however, we are not told if there was a placebo group (sham operation) and/or blinding of evaluators. The story does not mention that the results of these studies have not yet been reviewed in a peer-reviewed journal, and material in this story is from press conferences and government press releases.
The story mentions male circumcision as a method of reducing the transmission of HIV, but it appropriately notes safer sex practices such as condom use for greater protection against HIV. The story provides absolute numbers, but what is not mentioned is that the absolute number of avoided infections will be low in lower prevalence populations, so the risks of complications may outweigh the potential benefits for an individual at low risk.
The story notes that this is a routine surgical procedure with few compilations and mentions potential harms of male circumcision such as mild infections, but there is no peer-reviewed data listed on rates of complications from this or other clinical trials. What is stressed in the press release, but not the article, is that this procedure should only be performed by a medical professional who can also provide appropriate post-operative care during the healing period. Availability of safe circumcision and safe postoperative care is far from certain around the world. The story does not mention the cost of adult male circumcision outside of a clinical trial, and it is not clear whether insurance companies cover this procedure for adult males in the U.S. when no acute problem exists.
The story quotes an NIH official for perspective on the results of these studies. But since the NIH sponsored the study, he does have an interest in its outcome. There are experts who would disagree with public health-related mass circumcision programs, for reasons both cultural and related to quality of life.
The story does not mention the cost of adult male circumcision outside of a clinical trail. It is also not clear whether this is a reimbursible procedure for adult males in the USA when no acute problem exists.
The story appropriately describes the design of the two similar studies and provides both absolute and relative evidence that male circumcision reduces a man's risk of acquiring HIV via heterosexual sex. The story also mentions that the trials were stopped early because the benefit of male circumcision so significantly reduced the risk of acquiring HIV that it would be unethical to continue a trial in which uncircumcised men were not offered this protection. What is not mentioned is that the absolute number of avoided infections will be low in lower prevalence populations, so the risks of complications may outweigh the potential benefits for an individual of low risk.
The story mentions potential harms of male circumcision such as mild infections. These are treatable and rare, especially when the procedure is performed by a trained medical professional. However, it is difficult to assess the negative consequences of surgery as no publication of adverse events is reviewable. It is also possible that side effects or negative consequences in the real-world (rather than a clinical trial) would be more common.
The story doesn't explain whether there was a placebo arm of the study. Was there a sham operation? If so, were patients and evaluators blinded regarding treatment? This is a key indicator of study quality that is not commented upon. (One could posit that there is a reduced frequency of sexual encounters after this surgery, and this is the critical predictor of reduced acquisition of HIV, not the surgery itself.)
The story does not engage in disease mongering.
The story quotes an NIH official for perspective on the results of these studies. But since the NIH sponsored the study, he does have an interest in its outcome. It also quoted representatives of the World Health Organization and the Global AIDS Alliance. There are experts who would disagree with public health-related mass circumcision programs, for reasons both cultural and related to quality of life.
The story mentions male circumcision as one method of reducing the transmission of HIV. But the story also mentions safer sex practices such as using condoms for better protection against HIV.
The story reports on two large studies of male circumcision and reduced HIV in African heterosexual men. We are not told if these studies have been reviewed in a peer-reviewed journal or where they will be published.
The results of these studies may be applicable regardless of geography: While more male infants are routinely circumcised in the U.S. than in Africa, this surgery is available for uncircumcised adult men in the U.S. who wish to reduce their risk of HIV transmission from heterosexual sex. Other protection against the HIV is still necessary. The story does note that this is a routine surgical procedure with few compilcations. What is stressed in the press release, but not the article, is that this procedure should only be performed by a medical professional who can also provide appropriate post-operative care during the healing period. Availability of safe circumcision and safe postoperative care is far from certain around the world.
It is clear from the story that the link between male circumcision and HIV prevention was noted as long ago as the late 1980s.
The story used several independent experts for comment, so it appears unlikely that it relied solely or largely on a news release.
Systematic, Criteria-Driven
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like